CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,123 | +22.4% | 5,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $120,150 | +102592.3% | 5,400 | +0.4% | 0.00% | 0.0% |
| Q1 2023 | $117 | -33.1% | 5,380 | -37.5% | 0.00% | 0.0% |
| Q4 2022 | $175 | -99.9% | 8,610 | +0.1% | 0.00% | -50.0% |
| Q3 2022 | $233,000 | +14.8% | 8,599 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $203,000 | +5.7% | 8,540 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $192,000 | -42.7% | 8,540 | -52.2% | 0.00% | -66.7% |
| Q4 2021 | $335,000 | +11.3% | 17,873 | +17.0% | 0.00% | +50.0% |
| Q3 2021 | $301,000 | +192.2% | 15,271 | +225.6% | 0.00% | +100.0% |
| Q2 2021 | $103,000 | -8.0% | 4,690 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $112,000 | -8.9% | 4,690 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $123,000 | -54.4% | 4,690 | -69.8% | 0.00% | -50.0% |
| Q3 2020 | $270,000 | -57.8% | 15,523 | -59.2% | 0.00% | -66.7% |
| Q2 2020 | $640,000 | +251.6% | 38,066 | +149.2% | 0.01% | +200.0% |
| Q1 2020 | $182,000 | -1.6% | 15,275 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $185,000 | +6.9% | 15,275 | +24.5% | 0.00% | 0.0% |
| Q3 2019 | $173,000 | +2783.3% | 12,270 | +2052.6% | 0.00% | – |
| Q2 2019 | $6,000 | -14.3% | 570 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -56.2% | 570 | -51.3% | 0.00% | – |
| Q4 2018 | $16,000 | 0.0% | 1,170 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -11.1% | 1,170 | +1.7% | 0.00% | – |
| Q2 2018 | $18,000 | +157.1% | 1,150 | +155.6% | 0.00% | – |
| Q1 2018 | $7,000 | -61.1% | 450 | -55.0% | 0.00% | – |
| Q4 2017 | $18,000 | -5.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $19,000 | +58.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | +200.0% | 1,000 | +150.0% | 0.00% | – |
| Q1 2017 | $4,000 | -81.8% | 400 | -86.7% | 0.00% | – |
| Q4 2016 | $22,000 | +10.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2016 | $20,000 | +25.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2016 | $16,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |